🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The aim of this research project is to test the feasibility and safety of a...
Status
Unknown
Location
European Institute of oncology
Start Date
2015-05
Trial ID
NCT02672449
Treatments Being Tested
The purpose of the study is to evaluate the role of hypofractionated in the...
Status
Unknown
Location
David Cantu de Leon
Start Date
2017-11-10
Trial ID
NCT03750539
Treatments Being Tested
Primary Objectives: * To evaluate the results of Paclitaxel and pelvic rad...
Status
Completed
Location
M. D. Anderson Cancer Center - Orlando
Start Date
2001-04
Trial ID
NCT00515073
Treatments Being Tested
The study is a prospective and observational cohort study. The purpose is t...
Status
Unknown
Location
Frist Affliated Hospital of Sun Yat-sen University
Start Date
2020-04-01
Trial ID
NCT04365049
Treatments Being Tested
A randomized study of 131 patients. Patients with a clinical T2-3 N0-1 rect...
Status
Recruiting
Location
UT Southwestern Medical Center
Start Date
2017-04-25
Trial ID
NCT03051464
This randomized phase II/III trial studies how well standard of care therap...
Status
Completed
Location
University of Alabama at Birmingham Cancer Center
Start Date
2014-12-24
Trial ID
NCT02364557
Treatments Being Tested
Chemoradiotherapy has become the standard of care for women with locally ad...
Status
Completed
Location
University Medical Center Groningen
Start Date
2010-03
Trial ID
NCT01088347
Treatments Being Tested
The purpose of this study is to determine whether the treatment of locally ...
Status
Completed
Location
Department of Radiation Oncology, Shandong Cancer Hospital and Institute
Start Date
2009-01
Trial ID
NCT00815308
Treatments Being Tested
This prospective phase II trial study aims to optimize the increase in dose...
Status
Completed
Location
CHU de Besançon
Start Date
2011-06-06
Trial ID
NCT02880007
Treatments Being Tested
To observe the efficacy and safety of hydrochloride anlotinib combined with...
Status
Unknown
Location
Multiple Locations
Start Date
2023-07-01
Trial ID
NCT05772377
Treatments Being Tested